Content
03/20/2025
Kirkland, WA USA
Cardiac Dimensions
completed $53 million Series E Round funding. Investors include
Ally Bridge Group (lead), Claret Capital Partners, Hostplus, M.H. Carnegie, Lumira Ventures.
About
Cardiac Dimensions develops minimally invasive treatment modalities to address heart failure and associated cardiovascular conditions. Its flagship technology, the Carillon Mitral Contour System®, is designed to address functional mitral regurgitation (FMR) using a catheter-based approach.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
